RAD 2025: Renowned AD investigator Kircik provides the history behind the classwide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.
Leon Kircik, MD
Advertisement
Articles by Leon Kircik, MD
Advertisement
Latest Updated Articles
Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MDPublished: June 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Oral Agent ALZ-801 Slows Brain Atrophy and Cognitive Decline in APOE4 Homozygotes with Early AD
2
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
3
FAQs On The Critical Window Hypothesis for Menopausal Hormone Therapy's Neuroprotective Effects
4
MHT and Alzheimer Risk: New Evidence for a Critical Window, with Roksana Karim, MD, PhD
5
